Robey Dennison MD is categorized under Pathological Laboratories in Florence, SC and active since 2003.
Robey Dennison MD was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dennison Robey at the company’s single location by writing to 805 Pamplico Highway # B210, Florence, South Carolina SC 29505 or by phoning (843) 664-4314. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Robey Dennison MD |
Contact Person: | Dennison Robey |
Address: | 805 Pamplico Highway # B210, Florence, South Carolina 29505 |
Phone Number: | (843) 664-4314 |
Website Address: | pdpathology.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pathological Laboratories |
SIC Code: | 8071 |
NAICS Code: | 6211110 |
Share This Business: |
Robey Dennison MD was started in 2003 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dennison Robey for inquiries that concern Robey Dennison MD by calling the company number (843) 664-4314, as your correspondence is most welcome. Additionally, the physical location of the single location of Robey Dennison MD can be found at the coordinates 34.15842,-79.75379 as well as the street address 805 Pamplico Highway # B210 in Florence, South Carolina 29505.
For its online presence, you may visit Robey Dennison MD’s website at pdpathology.com and engage with its social media outlets through on Twitter and on Facebook.